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ABSTRACT
RNA dimerization is an essential step in the retro-
viral life cycle. Dimerization and encapsidation
signals, closely linked in HIV-2, are located in the
leader RNA region. The SL1 motif and nucleocapsid
protein are considered important for both pro-
cesses. In this study, we show the structure of the
HIV-2 leader RNA (+1–560) captured as a loose
dimer. Potential structural rearrangements within
the leader RNA were studied. In the loose dimer
form, the HIV-2 leader RNA strand exists in vitro as
a single global fold. Two kissing loop interfaces
within the loose dimer were identified: SL1/SL1
and TAR/TAR. Evidence for these findings is pro-
vided by RNA probing using SHAPE, chemical
reagents, enzymes, non-denaturing PAGE mobility
assays, antisense oligonucleotides hybridization
and analysis of an RNA mutant. Both TAR and SL1
as isolated domains are bound by recombinant
NCp8 protein with high affinity, contrary to the
hairpins downstream of SL1. Foot-printing of the
SL1/NCp8 complex indicates that the major binding
site maps to the SL1 upper stem. Taken together,
these data suggest a model in which TAR hairpin III,
the segment of SL1 proximal to the loop and the PAL
palindromic sequence play specific roles in the
initiation of dimerization.
INTRODUCTION
Retroviruses selectively encapsidate a dimeric RNA
genome assembled from two identical positive sense
strands interacting near their 50-ends. It is presumed that
in the case of HIV-2, co-translational capture of the
full-length RNA by the nucleocapsid (NC) domain of
Gag ensures encapsidation speciﬁcity (1). The RNA
motifs important for interaction with the Gag protein
are located in the leader RNA region (50-UTR) that
contains highly structured domains which play various
regulatory roles in viral replication (2).
The essential motif for HIV-1 dimerization has been
extensively studied and is called the dimerization initiation
site (DIS) (3) or stem-loop 1 SL1 (4). In vitro studies using
short RNA constructs (5) showed that two DIS RNA
molecules interact via a kissing-loop forming a loose
dimer that may be further stabilized into an extended
duplex (tight dimer). However, it has been shown that
HIV-1 can replicate in the absence of the functional DIS
(6), and the extended structure of the entire 50-UTR dimer
has not been conﬁrmed (7). Loose dimers could be
detected only under native electrophoretic conditions
(TBM); they dissociate during semi-native gel electrophor-
esis (TBE).
Because the mechanism of dimerization and encapsida-
tion of HIV-2 differs somewhat from that of HIV-1
(8–10), HIV-1 RNA cannot be packaged into HIV-2
virions (1). Two dimerization signals within the HIV-2
leader RNA have been proposed: SL1 (similar to HIV-1
SL1) (11,12) and a self-complementary sequence located in
the PBS (10). Alternate usage of these sites (13) and in-
volvement of TAR RNA (trans-activation responsive
region) (14,15) in the dimerization have also been sug-
gested. Similarly to HIV-1 (16), the LDI/BMH global
riboswitch was proposed (17) in which presentation of
the SL1 apical loop palindrome and its ability to
dimerize are inﬂuenced by structural rearrangements of
the entire HIV-2 leader RNA. In the case of HIV-1,
in vivo RNA structural probing (7,18) did not conﬁrm
the riboswitch model. Also similar to HIV-1 (6), HIV-2
can replicate without the SL1 apical loop palindrome.
Certain mutants with deletions and/or substitutions in
SL1 had no effect on viral replication, while mutations
in the  region (encompassing the sequence between the
PBS and SL1) were found to be strongly inhibitory
(19,20). Within this region, a 10-nt palindromic sequence
called PAL (+392–401) is believed to play an important
regulatory role in HIV-2 dimerization (12,20). Speciﬁcally,
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sequence immediately downstream of SL1. This motif,
referred to as stem B, effectively stabilizes SL1 and
prevents its participation in the extended interstrand
base pairing predicted to exist in tight dimers (8,21). A
different SL1 secondary-structure model has also been
proposed in which only a short hairpin encompassing
+409–436 residues is formed and the PAL sequence
either remains unconstrained (9,12,22,23) or interacts
with the upstream region (+377–386) to form a separate
stem-loop motif (19,24). A model of dimerization
regulated by alternate presentation of the PAL and SL1
sequences produced by local RNA rearrangements in the
monomeric RNA has also been suggested (24).
A regulatory role in HIV dimerization has also been
proposed for the long-range U5-AUG interaction, referr-
ing to the base-pairing of a C-rich sequence located be-
tween the poly(A) and PBS domains with a G-rich
sequence around the Gag translation initiation region
(9,12,25). The HIV-2 U5-AUG is abbreviated CGI
[C-box/G-box interaction; (8)]. In contrast to HIV-1, for-
mation of U5-AUG duplex impairs HIV-2 RNA tight di-
merization, probably due to intramolecular entrapment of
the SL1 motif (8).
The dimerization and encapsidation signals are closely
linked in HIV-2 and the NC protein (abbreviated NCp8),
as a domain of Gag, is involved in both processes (19).
The NC protein contains two zinc ﬁnger motifs. The
HIV-1 protein (NCp7), rich in arginine and lysine, has
been shown to be a potent chaperone for both nucleic
acid folding and unfolding (26), and sites of interaction
between NCp7 and HIV-1 RNA have been characterized
(7,27,28).
Our knowledge of interactions between NC protein and
the HIV-2 leader RNA is based mostly on the results
obtained using GST tagged NCp7 together with HIV-2
leader RNA (27). Although NCp7 and NCp8 share 67%
similarity, differences in packaging and dimerization have
been reported for HIV-1 and HIV-2 (1,8,10). Both zinc
ﬁnger motifs in HIV-2 NC have been shown to speciﬁcally
interact with viral RNA during genome encapsidation
(29), which is in marked contrast to HIV-1 (30).
Moreover, although previous studies have demonstrated
site-speciﬁc contacts between HIV-1 NC and structural
elements within the leader region of HIV-1 RNA (27),
similar interactions between NCp8 and HIV-2 leader
motifs have yet to be identiﬁed.
The results of in vitro structural mapping of the HIV-2
leader RNA (+1–560nt) and shorter transcripts repre-
senting motifs considered important for dimerization,
encapsidation and interactions with NCp8 protein are pre-
sented. The proposed secondary structure of the HIV-2
leader RNA represents a single global fold captured
in vitro as a loose dimer. Two contact interfaces in the
loose dimer form were identiﬁed within the SL1 and
TAR motifs. Recombinant HIV-2 NC exhibits tight bind-
ing to SL1 (Kd=125±25nM) and TAR (Kd=450±
50nM), but poor binding to hairpin motifs at the leader
30-end (1, SD, 2 and 3). Our in vitro results allow us




The DNA templates for in vitro transcription were
generated by PCR ampliﬁcation of the plasmid HIV-2 
large (31) containing a T7 promoter directly upstream of
the +1 position of the wild-type HIV-2 ROD sequence.
PCR primers used for template preparation are presented
in Supplementary Table S1 (see Supplementary Data).
The DNA template for the UTRh3 mutant was generated
using the megaprimer PCR method (32). All PCRs were
performed under identical conditions using Ambion
SuperTaq
TM Plus polymerase and conditions described
earlier (33). All the RNA transcripts were synthesized
with the Ambion T7-MEGAshortscript following the
manufacturer’s protocol. Transcripts were puriﬁed by de-
naturing gel electrophoresis (8M urea), followed by
elution and ethanol precipitation. Puriﬁed RNAs were
dissolved in sterile water and stored at  20 C.
Oligoribonucleotides (TAR hairpin III, SL1 upper part,
1, SD, 2 and 3), Cy5-labelled DNA and 20-O-
MeRNA were created by chemical synthesis using
solid-support aided phosphoramidite chemistry, and in
the case of RNA, 20-O-TOM protected phosphoramidites
(Glen Research) were utilized. Fluorescent labels were
introduced at the 3’-end using commercial Cy5-modiﬁed
solid supports (Glen Research). After deprotection, oligo-
mers were puriﬁed by denaturing gel electrophoresis
(8M urea), followed by elution and desalting on NAP
columns (Amersham Biosciences).
RNA labelling
RNA molecules were labelled post-transcriptionally
with
32P at the 50-end or intramolecularly during
in vitro transcription with [a-
32P]-GTP (Ambion
T7-MEGAshortscript). 50-end-labelling of RNA mol-
ecules with
32P was performed using [g-
32P]-ATP (ICN)
and the Ambion KinaseMax kit according to the protocol.
Oligonucleotides obtained by the chemical synthesis were
50-end-labelled using [g-
32P]-ATP and T4 polynucleotide
kinase (Fermentas) according to protocol. Labelled RNAs
and DNA primers were puriﬁed by denaturing PAGE,
followed by elution in water and ethanol precipitation.
Samples were dissolved in sterile water and stored
at  20 C.
In vitro dimerization of HIV-2 RNAs
The homogeneity of all RNA molecules was checked by
denaturing PAGE. Aliquots of
32P-labelled RNAs
(5–10pmol) in sterile water were denatured at 90 C for
1min. A buffer containing 10mM Tris–HCl (pH 7.5),
130mM KCl, 0.5mM EDTA and the appropriate
MgCl2 concentration (0–5mM) was added followed by
slow cooling to room temperature. Loose dimer formation
was also tested under SHAPE folding and buffers condi-
tions (see below). For tight dimerization, RNA was
incubated at 65 C for 10min and then at 37 or 55 C.
For the loose dimer formation, the 65 C incubation was
omitted and RNA was incubated at 37 C. The dimeriza-
tion time was established individually for each transcript
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formers, the samples were kept on ice for 1min, then 2ml
30% glycerol or 25% Ficoll were added and samples were
loaded directly onto the gel. The process of RNA dimer-
ization was studied using gel electrophoresis under native
(TBM, 4 C) or semi-native (TBE, 4 C) conditions. As a
control, RNA denatured in formamide (5min/100 C) was
also loaded onto the gel.
HIV-2 RNA structural studies using antisense
oligonucleotides
RNA molecules were labelled with
32P, and oligonucleo-
tides with Cy5 or unlabelled. RNAs (5–10pmol) were
folded as described for the dimerization assays and incu-
bated at 37 C for 5 to10 min. The dimerization buffer with
5mM MgCl2 was used. Subsequently, the appropriate
oligonucleotide (DNA or 20-O-MeRNA) was added in a
10- and 20-fold molar excess and the samples were
incubated at 37 C. The loose dimerization was allowed
to proceed for an additional 15min. For analysis of
tight dimers the incubation time varied according to tran-
script length as follows: 2h for+1–560 RNA and 10min
for shorter transcripts encompassing the leader 30-end.
The samples were kept on ice for 1min, 2ml of 30%
glycerol or 25% Ficoll were added and the samples were
loaded directly onto a TBM or TBE gel (4 C).
In silico two-dimensional RNA structure prediction
Two-dimensional (2D) RNA structures were predicted
using RNAstructure PC v. 4.3 or 4.6 with default
settings applied (34). We considered all the secondary
structures predicted within 20% of free energy of the
most stable variant, subsequently changing the window
size parameter to generate closely related structures. For
the SHAPE-constrained folding, default parameters of
RNAstructure PC v. 4.6 were used.
Enzymatic structural probing of RNA
Limited digestions with nucleases S1 (Fermentas), RNase
T1 (Boehringer), RNase V1 (Ambion) and RNase A of the
50-end-labelled target RNAs (30000c.p.m. per sample)
were performed in a buffer containing 10mM Tris–HCl
(pH 7.2), 40mM NaCl, 8mM carrier RNA (Ambion) and
5mM MgCl2. Prior to the reactions, RNAs were refolded
by heating at 90 C for 1min in reaction buffer and slow
cooling to 37 C. The renatured RNAs were incubated for
10min at 37 C with increasing concentrations of the re-
spective enzyme: T1 (0.2–0.4U), V1 (0.01–0.0025U), A
(0.1–0.01ng) or S1 (0.5–1U). For limited digestion with
RNase III (Ambion), the reaction was carried out at 37 C
for 5min with 0.5 or 1U of enzyme. Reactions were
terminated by addition of an equal volume of stop
buffer (8M urea, 20mM EDTA, 0.02% xylene cyanol
and 0.02% bromophenol blue) and freezing on dry ice.
Mapping oligodeoxynucleotide hybridization within the
HIV-2 leader RNA
Prior to the reaction, RNAs (30000c.p.m.) were subjected
to refolding as described above. Subsequently, 2 pmols of
appropriate oligodeoxynucleotide were added and the
mixture was incubated for 10min at 37 C. The hybridiza-
tion sites were detected using 0.25–0.5 U of RNase H at
37 C for 5min. Reactions were quenched by the addition
of an equal volume of stop buffer and freezing on dry ice.
Chemical structural probing of RNA
Probing with DEPC. For chemical probing with diethyl-
pyrocarbonate (DEPC), the target 50-end-labelled RNAs
(50 000c.p.m) were refolded as described above. Reactions
(10ml) with 0.5ml DEPC were allowed to proceed for 5, 15
or 30min at 37 C. Samples were ethanol precipitated twice
in the presence of 5mg carrier RNA (Ambion) and treated
with 10ml of 1M aniline–acetate buffer (pH 4.5) according
to standard protocol (35). Before electrophoresis, the
RNAs were dissolved in 5ml of sterile water and an
equal volume of formamide with tracking dyes.
Pb
2+ ion-induced cleavage. Prior to Pb
2+ ion-induced
cleavage, RNA transcripts (30000c.p.m.) were subjected
to refolding as described above with a reaction buffer con-
taining 10mM Tris–HCl (pH 8.0), 40mM NaCl, 8mM
carrier RNA and 5mM MgCl2. Afterwards, freshly
prepared Pb(OAc)2 solution was added to a ﬁnal concen-
tration of 0.25, 0.5, 1 and 2mM and the reaction mixtures
were incubated for 15min at room temperature (36,37).
Reactions were quenched by the addition of an equal
volume of stop buffer and freezing on dry ice.
All products of nuclease digestion and chemical
cleavage were analysed by denaturing PAGE in 1 
TBE. In order to assign RNA cleavage sites, reaction
products were subjected to electrophoresis along with
the products of alkaline RNA hydrolysis (formamide
with 3mM MgCl2 at 100 C for 20min) and limited T1
nuclease digestion [0.2U, 50mM sodium citrate (pH 5.3)
and 7M urea at 55 C for 10min] of the same RNA.
NMIA treatment of RNAs. RNAs (20 pmols) were heated
at 90 C for 1min in 20ml of renaturation buffer [10mM
Tris–HCl (pH 7.5), 100mM KCl, 0.1mM EDTA] and
slowly cooled to 4 C. Subsequently, 97ml of water and
29mlo f5   folding buffer [200 mM Tris–HCl (pH 7.5),
650mM KCl, 2.5mM EDTA, 25mM MgCl2 and 40U
RNase inhibitor] were added and the RNA was incubated
at 37 C for 10min. For NMIA modiﬁcation reactions
taking place in the presence of oligonucleotides, it was
at this point that the oligonucleotide was added,
followed by the incubation for 10min at 37 C. The
mixture was divided into equal parts, treated with 7.3ml
of 180mM NMIA in anhydrous DMSO (+) or DMSO
alone ( ) and allowed to proceed at 37 C for 50min.
The RNA was precipitated and resuspended in 10mlo f
water. Modiﬁed sites were detected by primer extension,
followed by electrophoretic fragment separation.
The primer extension reactions were performed as
described earlier (38) except that 5mM DTT and 1M
betaine were added. Dideoxy sequencing markers were
generated using unmodiﬁed RNA. Several 50-end-labelled
DNA primers were used to analyse the entire HIV-2 leader
RNA or shorter transcripts derived from it. The sequences
of these primers are provided in Supplementary Table S2.
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integrated using SAFA (39) and corrected for stochastic
drop-off (40). The control reaction ( ) was subtracted
from NMIA reaction (+) and SHAPE reactivities were
normalized to a scale in which 0 indicates an unreactive
residue and the average intensity at highly reactive
residues is set to 1.0, as described previously (7).
Cloning of recombinant HIV-2 NC protein
A synthetic gene was designed based on the sequence of
the HIV-2ROD NC protein (NCp8) taken from http://
ncbi.nml.nih.gov. The gene sequence was codon optimized
and engineered to contain the EcoRI restriction site at its
50-end and the BamHI restriction site at its 30-end. This
gene was synthesized based on a PCR method utilizing
single-stranded overlapping oligonucleotides. The PCR
product was puriﬁed by phenol extraction and ethanol
precipitation. After EcoRI and BamHI digestion (37 C/
1h), phenol extraction and ethanol precipitation, this
insert was cloned into the pGEX-4T-3 expression vector
as a GST fusion gene. The identity of the clone was con-
ﬁrmed by nucleotide sequencing.
HIV-2 NC protein expression and puriﬁcation
The GST-NCp8 protein was expressed in Escherichia coli
BL21—Codon Plus (DE3)—RIL cells (Stratagene) and
puriﬁed by afﬁnity chromatography on Glutathione-
Sepharose (Amersham Pharmacia Biotech.) using a
batch puriﬁcation method. E. coli cells were grown in
the LB medium at 37 C to an A600 of 0.5, after which
expression of GST-NCp8 was induced with 1mM IPTG.
The cells were harvested 4h after induction by centrifuga-
tion (4000rpm, 15min, 4 C) and resuspended in 50ml
lysis buffer [50 mM Tris–HCl (pH 7.9), 100mM KCl,
1% Triton X-100, 50mM DTT, 0,1mM PMSF, 2mg/ml
benzamidine]. The cells were lysed by three repeated freeze
and thaw cycles ( 80 C/0 C), followed by sonication. The
cell debris was pelleted by centrifugation (15 000rpm,
40min, 4 C), the resulting supernatant was mixed with
2ml Glutathione-Sepharose and incubated with gentle
agitation at 4 C for 2h. The suspension was centrifuged
(1500rpm, 2min, 4 C) and the beads were washed twice
with 10ml buffer I [PBS (pH 7.4), 1% Triton-X 100,
50mM DTT, protease inhibitors (Roche)], 10ml buffer
II [50 mM Tris–HCl (pH 7.5), 300mM NaCl, 50mM
DTT, protease inhibitors], 10ml buffer III [50 mM Tris–
HCl (pH 7.5), 100mM KCl, 10% glicerol, 50mM DTT]
and 10ml cleavage buffer [50 mM Tris–HCl (pH 7.5),
20mM KCl, 10mM DTT]. Cleavage of the GST-NCp8
fusion protein with thrombin (10 U) occurred overnight at
4 C (mixture volume up to 0.5ml), and the protein was
stored at 4 C in cleavage buffer. The yield was  5mgof
puriﬁed protein per liter of culture media.
Protein expression and puriﬁcation were monitored by
SDS–PAGE and Coomassie Brilliant Blue staining.
Molecular mass determination was performed using an
Autoﬂex MALDI TOF mass spectrometer (Bruker
Daltonics).
NCp8/HIV-2 RNA gel retardation assay
Prior to the binding reaction, RNA samples labelled with
32P were refolded. RNA–protein complex formation
(volume 10ml) was carried out in a buffer containing
50mM Tris–HCl (pH 8.0), 20mM KCl, 100mM DTT,
0.1% Triton X-100 for 10min on ice. The binding was
tested at different ZnCl2 (0–100mM) concentrations. In
order to test the NCp8 binding speciﬁcity reactions were
carried out in the presence of 100-fold molar excess
of carrier RNA (Ambion). The complexes were mixed
with 2ml of 25% Ficoll with dyes and loaded directly
onto a non-denaturing polyacrylamide gel (acrylamide/
bisacrylamide, 75:1) containing 0.5  TB with 0.1%
Triton X-100. Electrophoresis was carried out at a low,
strictly controlled gel temperature (4 C). The equilibrium
constants (Kd=[NC][RNA]/[NC–RNA]) were estimated
using 1pmol RNA and dilutions of NCp8 [from 50nM
to 2mM for TAR, poly(A) and SL1; 500nM to 50mM for
1, SD, 2 and 3].
Mapping the RNA binding sites for NCp8
The NCp8 binding sites within the RNAs were detected
using Pb
2+ ion-induced cleavage. NCp8/HIV-2 RNAs
complexes were formed as described above, followed by
addition of carrier RNA (0.5mg, Ambion) and Pb(OAc)2
solution to ﬁnal concentration 2mM and by incubation
for 10min at 0 C. The reactions were quenched by the
addition of 40ml of 2mM EDTA and ethanol precipita-
tion. The reaction products were analysed by denaturing
PAGE in 1  TBE.
Results from all PAGE experiments with radiolabelled
or ﬂuorescently labelled RNAs and DNAs presented in
this study were visualized and quantitatively analysed
using a Typhoon 8600 Imager with ImageQuant
software (Molecular Dynamics) or an FLA-5100 with
MultiGaugeV 3.0 (FujiFilm).
In all cases, at least three independent experiments were
performed, and the data presented are representative of
the whole.
RESULTS
HIV-2 leader RNA loose dimer structure
The secondary-structure model of the HIV-2 leader RNA
is based on the enzymatic and chemical probing data
related to the monomer state (17,23). Although several
studies attempted to address rearrangements occurring
within the leader RNA upon dimerization (17,22,24), the
structure of the HIV-2 leader RNA dimer is still unknown.
To reveal the HIV-2 leader RNA loose dimer structure, we
applied the SHAPE method (41) which had been success-
fully used to identify kissing-loop interactions (40,42).
The length of the HIV-2 leader RNA, encompassing
+1–546nt, was extended to 560nt to include a fragment
of the Gag coding sequence proposed to be involved in the
U5-AUG duplex formation (Figure 1A) (8,9). Analysis of
the 560-mer leader transcript using TBM gels and differ-
ent folding conditions (Figures 1B, C and 2A) indicates
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the presence of Mg
2+. After 10min, over 50% of the RNA
was in the dimeric form (Figure 2A). The comparison of
TBM and TBE gel patterns shows that tight dimers, under
identical folding conditions, were formed very inefﬁciently
even after prolonged incubation (compare Figure 1C,
fourth lane and 1D). Consequently, under SHAPE
folding and NMIA modiﬁcation conditions (38), most of
the HIV-2 leader RNA molecules were in the loose dimer
form (Figure 2A).
Well-resolved SHAPE data, supported by native gel
patterns, point to the one global fold of the HIV-2
leader RNA (Figures 1C and 2 and Supplementary
Figure S1) captured in vitro in its stable loose dimer
state. In this dimeric structure, the TAR domain exists
in its branched form (43) (Figure 2B). This domain
(+1–123), in its isolated state for HIV-2 (33) and in vivo
for SIV (44), undergoes an interconversion between a
branched hairpin form and an extended form. The equi-
librium state in vitro is highly susceptible to the folding
conditions. Analysis of the isolated TAR migration on
native gels indicates that under SHAPE folding condi-
tions, the branched hairpin form prevails (Supplementary
Figure S2).
SHAPE indicates that the poly(A) domain (+125–184),
presented earlier as a hairpin with a large 29-nt apical loop
(45), is structured. Residues A144 to U149, C158 and
G160 to C162 were not modiﬁed by NMIA (Figures 2B,
C and 3D), suggesting that they are constrained.
Interestingly, three structural models were generated in
silico for the poly(A) domain, using RNAstructure
software (34), but none of the predicted structures ﬁt the
experimental data. To address whether those residues are
involved in long-range interactions with other domains of
the leader RNA, we performed extensive enzymatic
and chemical structure probing of the isolated poly(A)
hairpin encompassing+125–184 residues (Figure 3A and
C). RNase A, speciﬁc for single-stranded pyrimidines,
cleaved only 4 of 13 pyrimidines located in the apical
loop and none of the residues resistant to NMIA modiﬁ-
cation were recognized. In addition, residues C145–U149
and C158–C162 were cleaved by RNase V1 and not by
nuclease S1. The use of RNase III led to a strong cleavages
at U138 and U172 and two weaker hits at C162 and U134,
supporting the existence of a structured section within the
loop of the poly(A) hairpin. These and other ﬁndings are
summarized in Figure 3C. Our analyses exclude a possi-
bility that these unexpected structural features of the
Figure 1. (A) Organization of the HIV-2 leader RNA. (B) Loose dimer formation by wt HIV-2 leader RNA and its UTRh3 mutant, in the absence
or presence of antisense oligonucleotide probe1 (P1) (TBM agarose gel). (C) Inﬂuence of antisense oligonucleotides, probe1 (P1; directed to SL1) and
probe2 (P2; directed to TAR hairpin III), on the formation of the loose dimers by+1–560 RNA (TBM agarose gel). (D) Tight dimer formation of
the +1–560 RNA (TBE PAA gel). For analyses of dimer formation, samples were incubated at 37 C for the times indicated, with some sample
incubated for an additional 10 or 15min (parenthesis) in the presence of P1 and/or P2. Lanes F correspond to the formamide-denatured control
sample. RNA monomers are indicated as M, dimers as D. (E) NMIA modiﬁcation of the leader RNA mutant UTRh3. Lane ( ) represents control
sample with untreated RNA; lane (+) NMIA modiﬁcation, A, U, C and G are sequencing lanes.
7238 Nucleic Acids Research, 2011,Vol.39, No. 16Figure 2. (A) Analysis of the loose dimer formation by the HIV-2 leader RNA (+1–560) in the SHAPE buffers and folding conditions (TBM agarose
gel). (B) Secondary-structure model of the HIV-2 leader RNA captured in the loose dimer form. Two kissing-loop interfaces are indicated as black
frames. Nucleotide residues accessibilities to NMIA are given in colours and according to scale. (C) Processed SHAPE reactivities as a function of
nucleotide position. Red and orange bars reﬂect reactive positions in the RNA. Insert on the right represents the box plot analysis of distinct
reactivity distributions for the HIV-2 leader RNA. Box outline middle 50% of dataset; the median is shown with heavy line. Circles indicate extreme
values (7): 1.5 times the interquartile range (boxed). Horizontal lines above and below the box are the largest or smallest non-outlier values.
Nucleic Acids Research, 2011,Vol.39, No. 16 7239Figure 3. Structural probing of HIV-2 transcripts encompassing regions: (A)+125–184 and (B)+397–463. The RNAs were treated with single-strand
speciﬁc reagents (S1, T1, A, Pb
2+, DEPC) and double-strand speciﬁc RNase V1 and RNase III. Lanes C represent control samples with untreated
RNA; lanes L, formamide ladder. (C) Summary of enzymatic and chemical cleavages and modiﬁcations viewed on the secondary-structure models of
poly(A) and the SL1 domains. (D) NMIA modiﬁcation of poly(A) and SL1 regions in the HIV-2 leader RNA (+1–560). Lanes ( ) represent control
sample with untreated RNA; lanes (+) NMIA modiﬁcation, C and G are the sequencing lanes.
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ents of the leader RNA. In addition, our data rule out the
formation of a pseudoknot between nucleotide residues
within the apical loop of poly(A) and residues located in
the coding region, a structural feature which has been
recently proposed for HIV-1 (7).
The data obtained point to the extended SL1 forming
stem B (8,11,21), rather than the short hairpin (+409–436)
(9,12,22,23). Residues of the 30-end of PAL
(G397CUCC401) were not modiﬁed by NMIA and they
form the stem B of SL1 (Figures 2B, C and 3D). The
in vitro data obtained for the captured loose dimer
exclude the presence of in silico predicted stem-loop struc-
tures encompassing the  region containing the PAL
sequence (19,24). Based on enzymatic and chemical
probing data obtained for the shorter transcripts con-
taining SL1, we propose the existence of several non-
canonical base pairs closing bulges and loops within
the SL1 structure (Figure 3B, C and Supplementary
Figure S3).
Analysis of the data obtained for the HIV-2 leader
RNA 30-end (+380–560) (Figure 2B and C and
Supplementary Figure S1) conﬁrms the presence of char-
acteristic short hairpins 1, SD, 2 and 3 presented in a
previous model (23). In addition, the U5-AUG (CGI)
interaction (8,9) is conﬁrmed. The lack of NMIA modiﬁ-
cation indicates that residues G543 to C553 (G-box)
are paired with G186 to C196 (C-box). As presented in
Figure 2B and C and Supplementary Figure S1, the
analysis of the SHAPE data also supports base-pairing
between segments C385CACGAC391 and G535AUUGUG
G542.
The secondary-structure model of the HIV-2 leader
RNA proposed here is based on the modiﬁcation
pattern where single-stranded regions are reactive
towards NMIA (Figure 2B and C). However, two excep-
tions were found that are consistent with the presence of
tertiary interactions involved in the loose dimer forma-
tion. Both of them represent a kissing-loop interaction.
Speciﬁcally, the SL1 palindromic sequence G420GUACC
425 and a self-complementary sequence within the TAR
(U100UGGCCGG107) were largely unreactive towards
NMIA. The latter of those sites is located within the
short 30 hairpin of the TAR domain, and is characteristic
of both TAR forms (abbreviated herein as hairpin III).
Within the aforementioned sequence, only U101 which
is involved in an intermolecular G–U pair formation,
was found to be susceptible to NMIA modiﬁcation
(Figure 2C and Supplementary Figure S1). Similar to
the data obtained with SL1 (Figure 3B and C), the hairpin
III loop in the monomeric state was fully accessible to
several enzymes and chemical reagents used to probe the
isolated motif (+93–113) and a longer RNA encompassing
TAR (+1–123) (33). In addition, both short constructs
representing the upper part of the SL1 and the isolated
hairpin III of TAR were found to undergo the transition
from loose to tight dimers very efﬁciently (Supplementary
Figure S4). To further conﬁrm the participation of the
TAR hairpin III apical loop in formation of the
kissing-loop complex, an RNA mutant was constructed.
The U101GGCC105 sequence of the TAR hairpin III apical
loop was changed to A101AAAA105 in the UTRh3 mutant
of the HIV-2 leader RNA. The NMIA modiﬁcation
pattern obtained for the UTRh3 mutant transcript
(Figure 1E) shows that, contrary to the wild-type leader
RNA, residues of the hairpin III apical loop were reactive
towards NMIA. SHAPE data also showed that the sec-
ondary structure of the TAR domain in the mutant RNA
remained unaffected. The analysis of the dimerization
properties of UTRh3 RNA using TBM gels, indicates
that loose dimers were formed less efﬁciently relative to
the wild type HIV-2 leader RNA (Figure 1B).
Furthermore, the loose dimer formation was assayed in
the presence of an oligodeoxynucleotide complementary
to the apical loop and upper stem of SL1 (probe1)
(Figure 1B). The oligodeoxynucleotide was added to the
pre-folded RNA. Although the strong inhibitory effect of
probe1 was observed for both wild type and mutant RNA,
it should be emphasized that the presence of probe1
almost completely abolished UTRh3 loose dimerization.
In this case, one contact site is disrupted by the mutations,
and the second by hybridization with probe1. To extend
our ﬁndings on the interaction interfaces in the loose
dimer, we also tested the ability of the oligodeoxy-
nucleotide complementary to TAR hairpin III (probe2)
and SL1 (probe1) to suppress loose dimer formation of
the wild-type leader RNA (Figure 1C). While some reduc-
tion of loose dimerization was observed in the presence of
probe2, the effect was not as pronounced as for probe1.
However, when both probes were included in the hybrid-
ization mixture, the inhibitory effects on dimer formation
were additive (Figure 1C).
PAL/SL1 rearrangement
It has been proposed that the PAL sequence plays a regu-
latory role in SL1-mediated HIV-2 RNA dimerization and
monomeric RNA can adopt two alternative conform-
ations (24). The ﬁrst conformation, with an extended
SL1 and PAL partially base-paired in the stem B,
impairs dimerization. The second, with a short SL1
(+409–436) and PAL involved in formation of an add-
itional stem-loop motif (19), favours dimerization (24).
Because our studies of the leader RNA (+1–560) in the
conditions applied do not show indications of PAL/SL1
rearrangement, we decided to study this region within dif-
ferent structural contexts. A structural interconversion
that involves only a limited number of base pairs within
a relatively small region might be energetically more fa-
vourable in a shorter transcript. Transcripts +397–445,
+397–463, +377–463, +377–560 (Figure 3B and C and
Supplementary Figure S3) were subjected to structural
probing using selected single-strand speciﬁc (S1, T1, A)
and double-strand speciﬁc (RNase V1) enzymes and
chemical reagents (DEPC and Pb
2+ ions). The data
obtained show that in our in vitro conditions, the second-
ary structure of the extended SL1 remains unchanged re-
gardless of the presence of adjacent elements at the 50 and/
or 30-ends.
To allow direct comparison to the SHAPE data
obtained for the full-length leader RNA, two transcripts,
+377–560 and +397–560 were probed with NMIA
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contains the stretch of nucleotide residues that would
allow the proposed PAL/SL1 structural rearrangements
(24). NMIA reactivity proﬁles indicate that the structures
of transcripts+377–560 and+397–560 are the same, and
match that of the 30-end of the entire HIV-2 leader RNA
in vitro.
The structure of the HIV-2 leader RNA 30-end (+380–
560) was also analysed in the context of the+1–891 tran-
script. Although this transcript encompasses a much
larger fragment of the Gag coding sequence, no differ-
ences in the organization of leader RNA were found
(Supplementary Figure S1).
The features of the extended SL1 structure characteris-
tic of the isolated hairpin are retained within all RNAs
analysed, regardless of the additional 50 and/or 30 frag-
ments of leader RNA, indicating that adjacent structural
motifs fold independently. There is no evidence in these
data to suggest that multiple thermodynamically stable
forms of PAL/SL1 region exist in the monomeric RNA.
The SL1 palindrome is dispensable for the stability of the
tight dimer
The HIV-2 leader RNA forms tight dimers in vitro very
inefﬁciently (11,12). However, as reported earlier, forma-
tion of tight dimers was induced by folding the target
RNA in the presence of antisense oligonucleotides
directed against such regions as U5-AUG duplex, PAL
or SL1 (8,12). To investigate the structural properties of
the SL1 within the pre-folded leader RNA and to resolve
the inﬂuence of oligonucleotide probes on tight dimer for-
mation, a set of hybridization experiments was performed.
Initially we used an oligodeoxynucleotide (probe1) com-
plementary to the 50 upper stem and apical loop of SL1
(+407–426) of the same sequence as reported earlier for
the probe asSL1 (8,12). Probe1, labelled at the 30-end with
the ﬂuorescent marker Cy5, readily associated with the
pre-folded RNA present in a 1:1 ratio of monomer to
loose dimer. Inclusion of the probe1 in the mixture
led to an increase in leader RNA tight dimerization
(Figure 4A). The amount of dimer formed in the presence
of probe1 after 2h at 37 C is comparable to that obtained
without probe1 after 8h at 55 C. TBE gel patterns show
that the ﬂuorescent probe1 co-migrates with both the
monomer and the tight dimer. An RNase H assay con-
ﬁrmed that probe1 was bound at the expected location
within the SL1 domain. Residues G411 to C425 were
cleaved within the 377–560 RNA, indicating strand
invasion (Supplementary Figure S6).
To reveal the mode of action for probe1, two shorter
20-O-Me oligoribonucleotides 30-end-labelled with Cy5
were prepared: probe1A complementary to the apical loop
(+416–426) and probe1B complementary to the 50 upper
stem of SL1 (+407–417). Each of them was hybridized to
transcripts representing the 30-end of the leader RNA but
differing with respect to the presence of the  region en-
compassing the PAL palindrome (RNAs +377–560 and
+397–560). Transcript+377–560 contains the entire PAL
sequence, whereas +397–560 includes only the 30 part of
PAL (i.e. that involved in SL1 stem B formation). Probe1
and probe1A signiﬁcantly increased the level of tight
dimers for the +377–560 transcript, but not for the
+397–560 RNA (Figure 4B), indicating that the 
region plays a role in tight dimerization, as previously
proposed (20). In contrast, probe1B triggered an
increase in tight dimer formation for both transcripts,
indicating that tight dimerization induced by this probe
is  independent. However, in the case of the full-length
leader RNA (+1–560), the inﬂuence of probes 1A and 1B
on tight dimerization was not as pronounced as in the case
of probe1 (data not shown).
SHAPE was applied to reveal probe1-induced changes
within the full-length leader RNA structure. Probe1 was
added to the pre-folded leader RNA (monomer to loose
dimer ratio 1:1) and the resultant complexes were treated
with NMIA. Although the SHAPE readout represents the
superimposed reactivities of both free and bound leader
forms, some structural features are apparent (Figure 4C).
Interesting structural rearrangements are observed in the
SL1 stem B. Nucleotide residues G437–C443 showed an
increase of their reactivity towards NMIA in relation to
the leader alone. Residues G397–C401 remained unreact-
ive. These two stretches of residues in the monomeric
leader or its loose dimer fold into the SL1 lower stem
(stem B). In addition, the 50-end of the PAL was protected
from NMIA modiﬁcation and residues immediately
upstream gained reactivity. No additional changes in the
reactivity pattern of the leader RNA in the presence
of probe1 were observed (Figure 4C, Supplementary
Figure S7). This indicates that the rearrangements of the
secondary structure induced by probe1 are restricted to
the PAL/SL1 region. In addition, it shows that the SL1
apical loop is not involved in base pairing with other
regions of HIV-2 leader RNA.
The SL1 motif is a high-afﬁnity binding site for NCp8
An expression vector was constructed that generates the
HIV-2 ROD NCp8. The gene was cloned into the
pGEX-4T-3 vector as a GST fusion. The clone over-
expresses in E. coli efﬁciently and yields  5mg of pure
NCp8 protein after GST removal with thrombin
(Supplementary Figure S8A). The resultant protein con-
tains two additional residues at the N-terminus due to the
protease speciﬁcity. MALDI-TOF showed the expected
NCp8 molecular weight (Supplementary Figure S8B).
The speciﬁcity of NCp8 interaction with
32P-end-labelled RNA transcripts corresponding to
isolated domains of the 50-UTR has been analysed using
an electrophoretic mobility shift assay (EMSA). Titration
of the transcripts encompassing isolated domains: TAR,
poly(A), SL1, 1, SD, 2 and 3 with NCp8 resulted in
the formation of a new, distinct bands, albeit with differ-
ing intensities (Figure 5A and Supplementary Figure S9).
NCp8 has the highest afﬁnity for SL1 with a dissociation
constant of 125±25nM. At least three discrete bands
were formed, in accord with multiple proteins interacting
with RNA. Complexes remained unaffected in the
presence of 100-fold molar excess of an unrelated competi-
tor RNA, conﬁrming the speciﬁcity of the interaction
(Supplementary Figure S9). The NCp8/SL1 dissociation
7242 Nucleic Acids Research, 2011,Vol.39, No. 16constant is similar to that reported for HIV-1 NCp7 and
SL3 RNA (28).
Footprinting analysis of the NCp8/SL1 complex using
Pb
2+ induced RNA cleavage was performed under strin-
gent conditions that allow most of the base-paired nucleo-
tides to be cleaved. Titration of the +397–463 transcript
with NCp8 resulted in a decrease in RNA cleavages at
residues C410–C417 and A432–U438 at low-protein con-
centration (Figure 5B). This indicates that the SL1 upper
stem is the NCp8 binding site. Our structure probing data
obtained for isolated SL1 in the absence of protein show
that this binding site contains a purine–purine base pair
(G413–A432) next to the unpaired G414. The G414
residue was susceptible to Pb
2+ induced hydrolysis. The
lack of reactivity of the A432 residue towards DEPC
suggests that its Hoogsteen site is involved in base-pairing
with G413.
Footprinting analysis also demonstrates that cleavages
at C425 and C431 were enhanced at low protein
concentration, while in the presence of high concentra-
tions of NCp8 most of the residues previously protected
became reactive. The data are consistent with the
destabilizing activity of NC proteins on the RNA struc-
ture (46,47).
The afﬁnity of NCp8 for the other isolated hairpin
motifs present at the 30-end of HIV-2 leader RNA is
much lower than that for SL1. Kds for 1 and SD were
 4–5mM, for 2 5–6mM and >10mM for 3, suggesting
that the observed associations are likely the product of
nonspeciﬁc binding. Interestingly, a much higher afﬁnity
was observed for TAR and poly(A) isolated domains
(Kd=450±50and 550±50nM, respectively).
DISCUSSION
The HIV-2 leader RNA structure in the loose dimer form
It has been recently demonstrated that in vitro transcribed
HIV-1 leader RNA folds into the same structure as RNA
Figure 4. Inﬂuence of antisense oligonucleotide probes directed to SL1 domain on HIV-2 leader RNA tight dimerization. (A) Probe1-mediated
activation of +1–560 RNA tight dimerization (TBE). Time and temperature of incubation are indicated to describe differences in the conditions
necessary to achieve similar dimerization efﬁciency in the dimerization buffer with 5mM MgCl2.( B) The tight dimerization (TBE) of the +377–560
and +397–560 transcripts mediated by probes 1, 1A or 1B. Transcripts were
32P-labelled, oligonucleotide probes 30-end-labelled with Cy5
ﬂuorophore, the upper gel panels show radioactivity scans, the bottom, ﬂuorescence scans. Lanes F correspond to formamide-denatured control
samples; lanes C, control RNA dimerization in the absence of oligonucleotides. Monomers are indicated as M, dimers as D. Asterisks indicate RNA
produced by non-templated addition of nucleotides by T7 RNA polymerase. (C) NMIA modiﬁcation of the leader RNA after hybridization with
probe1 (5- and 10-fold molar excess). Lanes ( ) represent control sample with untreated RNA; lanes (+) NMIA modiﬁcation, C and G are
sequencing lanes.
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single fold (7). It was suggested that the HIV-2 leader
RNA monomer may adopt an alternative conformations
with different abilities to dimerize (17,24). Our results of
enzymatic and chemical structural probing, supported by
native gel electrophoresis, show that in the presence of
magnesium, the HIV-2 leader RNA strand shows prefer-
ence to exist in vitro as a single conformer. The data col-
lected from the SHAPE probing correspond to the leader
RNA loose dimer structure. This is due to the preferential
formation of the loose dimer by the HIV-2 leader RNA
and to the mild action of the NMIA reagent, which is
non-disruptive to the loose dimer (38,41,42).
To our knowledge, this is the ﬁrst study to structurally
characterize the HIV-2 leader RNA captured in one of the
potential kissing-loop complex forms. Here, we document
the existence of two contact interfaces involving palin-
dromes: the SL1 apical loop and the TAR hairpin III
apical loop. Although the involvement of the SL1 in di-
merization has been studied extensively, the role of the
SL1 apical loop has not been fully established yet. Some
reports underlined the importance of the SL1 apical loop
(11,12,17,24) while others disputed its involvement in di-
merization (10,20). Our data indicate that in vitro the SL1
apical loop palindrome contributes to the loose dimer for-
mation. Participation of the TAR domain in HIV-2 RNA
dimerization has also been suggested (14,15), but has not
been proven, as is the case for HIV-1 (15,48). However, it
was shown that deletion of the TAR caused a signiﬁcant
drop in the efﬁciency of HIV-2 leader RNA loose and
tight dimer formation in vitro (17). Based on our results,
we are able to support the involvement of TAR in dimer-
ization and to propose that TAR hairpin III serves as a
kissing-loop site. As we presented previously, a phylogen-
etic comparison of TAR sequences of HIV-2 and SIV
isolates revealed that this palindromic sequence is highly
conserved (33). The only notable change (present in three
different isolates) is the G106A substitution that would
not interfere with the palindromic character of this
sequence. Mutations in the TAR hairpin III palindrome
markedly reduced the amount of the loose dimer formed
in vitro (Figure 1B). Furthermore, the residues of hairpin
III apical loop were reactive towards NMIA in the
UTRh3 mutant (Figure 1E), contrary to the wild type
HIV-2 leader RNA. The oligodeoxynucleotides comple-
mentary to the SL1 (probe1) or TAR hairpin III
(probe2) suppressed the formation of loose dimers by
the wild type HIV-2 leader RNA (Figure 1C) supporting
the involvement of both motifs (TAR and SL1) in in vitro
dimerization. Less pronounced effect of probe2 may
reﬂect a supplementary role of the TAR hairpin III in
the dimerization or less efﬁcient hybridization of this
probe. In addition, the abolished formation of loose
dimers by the UTRh3 mutant in the presence of probe1
is an expected result in the light of our ﬁndings concerning
two main contact interfaces within the HIV-2 loose dimer.
Although our data indicate two contact sites in the HIV-2
RNA loose dimer, our focus was not on the Nar I
sequence and its participation in dimerization (10). It is
known that local RNA rearrangements occur upon
tRNA
Lys3 binding (49). Therefore, structural analysis of
that region is not emphasized here. However, we noted
Figure 5. NCp8 interactions with the isolated domains of the HIV-2 leader RNA. (A) Electrophoretic mobility shift assays for leader domains and
NCp8. The protein concentrations are indicated above the lanes. (B) Mapping the NCp8 binding sites within the +397–463 transcript using Pb
2+-
ions. Residues protected from cleavage in the presence of NCp8 are indicated by grey brackets.
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Nar I palindromic sequence were highly reactive towards
NMIA (Figure 2C).
Within the loose dimer, the global RNA fold merges
structural features of the previously proposed models of
the HIV-2 leader monomers (9,12,17,23). We found that
the structures of the individual domains within the
full-length HIV-2 leader RNA are similar of those of the
isolated ones. Results of detailed enzymatic and chemical
probing of the isolated domains are fully consistent with
the SHAPE data for the +1–560 and +1–891 transcripts
(Figures 2B, C and 3; Supplementary Figures S1 and S3).
Formation of the extended structure of SL1 is inde-
pendent of the structural context in which it is present,
indicating the stability of the SL1 stem B. The extended
SL1 had been previously shown to be necessary for HIV-2
replication and RNA encapsidation (21). We showed
that the extended SL1 and the intramolecular U5-AUG
are characteristic of the HIV-2 leader RNA loose dimer
structure (Figure 2B). A previous report, based on
the use of antisense oligonucleotide probes concluded
that the presence of U5-AUG duplex favoured the
extended SL1 motif formation (8,12). Although we
do not dispute the U5-AUG regulatory role in HIV-2
RNA dimerization, our structural probing data using
transcripts of different lengths clearly show that the
extended SL1 is formed irrespective of U5-AUG duplex
in vitro.
The SL1 RNA domain is a high-afﬁnity binding site for
NCp8
The NC proteins cover the entire retroviral leader RNA
with high occupancy. To address their binding speciﬁcity
and the structure of RNA/protein complexes, it is useful
to perform studies on models representing isolated RNA
domains (28,50). All individual HIV-2 leader RNA
domains except the PBS were incubated with recombinant
NCp8 protein (Figure 5A). Although we cannot exclude
the possibility that the binding afﬁnities of full length
Gag protein for the various constructs may differ from
those presented here for NCp8, the fact that SL1 RNA
is bound with an afﬁnity more than an order of magni-
tude higher than for 1, SD, 2o r3 is strongly sug-
gestive of speciﬁc recognition of this structural element by
HIV-2 NC.
Footprinting experiments reveal that the upper stem of
SL1 is the binding site for NCp8 (Figure 5B). An interest-
ing feature of this binding site is the presence of a purine–
purine base pair (G413–A432) next to the unpaired G414.
It has been demonstrated that the HIV-1 NC protein
prefers binding to unpaired G residues (28,51).
Moreover, our footprinting data demonstrate that NCp8
binding destabilizes SL1, in accord with the accepted
opinion that NC proteins destabilize continuous
double-stranded RNA structures (46,47,52).
The HIV-1 NC protein NCp7 binds the HIV-1 DIS
(SL1) and  (SL3) domains with similar afﬁnity, with
Kd’s ranging from 100 to 200nM (28). Interestingly, the
NCp8 dissociation constant for SL1 is much lower than
for other hairpins of the leader 30-end (Figure 5A). It has
been shown (27) that the heterologous NCp7 protein pref-
erentially binds the 3 domain within HIV-2 leader RNA
which structurally resembles the HIV-1 hairpin  (SL3).
The complex between the 3 hairpin and NCp8 was
studied by NMR (50). We observed that 3 cannot be
considered a speciﬁc binding site for NCp8 in vitro due
to the high Kd measured (above 10mM). Furthermore, the
3 motif is not essential for HIV-2 dimerization or
packaging (19). One can speculate that tight and prefer-
ential binding of SL1 by NCp8 supports the hypothesis
that the failure of HIV-2 to package the HIV-1 RNA may
in part be due to the differing speciﬁcities of the two NC
proteins.
Interestingly, NCp8 showed a much higher afﬁnity for
the HIV-2 TAR and poly(A) isolated domains than for the
hairpin motifs located downstream of SL1. The relatively
tight binding of NCp8 to the TAR domain is especially
interesting in view of the data presented here indicating
the involvement of the TAR hairpin III in the formation
of loose dimers. In addition, in clinical isolate from HIV-2
infected patients, a gag mRNA species exists that differs
from the genomic RNA due to the absence of the+61–202
intron in the leader region (53). An important question
in this case is how unspliced viral RNAs are differentiated
by Gag protein from those of the spliced species. The
intron contains half of the TAR structure and the
poly(A) hairpin. Our results with respect to NCp8
binding to the TAR and poly(A) domains may indicate
that these two important binding sites are missing in the
spliced RNA resulting in differentiation between both
RNA species.
Structural changes during the initiation of HIV-2 leader
RNA dimerization
Our results indicate that the HIV-2 leader RNA prefers to
form loose dimers in vitro, and in accordance with
previous reports (11,12), tight dimers were shown to
form very inefﬁciently (Figure 1D). However, tight dimer-
ization had been induced by antisense oligonucleotides
added prior to denaturation and subsequent folding of
the HIV-2 leader RNA (8,12). As this approach might
lead to substantial changes in the RNA fold, we added
the oligonucleotide probes to the pre-folded HIV-2
leader RNA at an equilibrium of 1:1 monomer to loose
dimer. The ﬂuorescent oligodeoxynucleotide probe1
promoted tight dimer formation, and stayed bound to
both the monomer and tight dimer species of the leader
RNA (Figure 4A). This allows us to conclude that the SL1
structures in both the monomer and loose dimer are sus-
ceptible to hybridization. However, the mechanism by
which probe1 participates in tight dimer formation was
difﬁcult to unravel in detail. Our data obtained for two
shorter 20-O-MeRNA probes 1A and 1B (Figure 4B) show
not only that both parts of probe1 are necessary for efﬁ-
cient induction of tight dimer formation, but also that
both the upper stem and apical loop of SL1 are
involved. Furthermore, the SHAPE probing revealed
that upon probe1-induced HIV-2 leader RNA tight dimer-
ization, SL1 stem B undergoes opening (Figure 4C), ex-
perimentally conﬁrming the previous hypothesis (8).
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of dimerization is due to the formation of dimerization-
competent short SL1 (+409–436) (8). Based on our data,
we conclude that this is a consequence of PAL release.
In other words, PAL becomes free to participate in alter-
nate interstrand base pairing interactions that stabilize the
tight dimer (Figure 6). Data obtained from experiments
with shorter transcripts representing the HIV-2 leader
RNA 30-end conﬁrmed the importance of PAL in SL1
mediated tight dimerization. The presence of the entire
PAL palindrome is necessary for the induction of RNA
tight dimerization by oligonucleotides complementary to
the SL1 apical loop (probes 1 and 1A). Interestingly, tight
dimerization of the transcript lacking the 50 part of PAL
sequence was promoted exclusively by probe1B, comple-
mentary to the SL1 upper stem. In this case, the tight
dimer could be formed only by the SL1 apical loop palin-
drome. These results suggest a possible functional
exchange between the PAL and SL1 palindromic se-
quences in the formation of intermolecular interactions
in vitro. It is also possible that for this transcript, desta-
bilization of the SL1 upper stem by probe1B induces a
conformation of the apical loop that favours tight dimer
formation.
The local conformational switch in the PAL/SL1 region
in the leader RNA monomer had been previously
proposed to regulate HIV-2 RNA dimerization (8,12,24),
but a compatible and comprehensive model showing the
structural rearrangements in this region was not estab-
lished. The importance of PAL in HIV-2 dimerization is
generally accepted, but its role is less understood
(12,20,24), and the participation of the SL1 apical loop
in this process is still a matter of dispute
(10,11,13,17,20). It should be emphasized that overall,
our data indicate that in monomeric leader RNA, PAL
forms stem B rather than the intramolecular structures
with nucleotides located upstream (19,24), while PAL in
the tight dimer is involved in the intermolecular PAL/PAL
interaction, which does not support the regulatory mech-
anism formerly proposed (24). We have also demonstrated
that the palindromic sequences in the SL1 apical loop and
TAR hairpin III, participate in loose dimer formation
in vitro. On the other hand, our observation that ﬂuores-
cent probe1 is bound to the species in the tight dimer form
(Figure 4A), supports the statement that the SL1 loop
palindrome is not necessary in vivo for the formation of
the dimers (20). We hypothesize that if the SL1 apical loop
palindrome is not present, the TAR hairpin III can sub-
stitute for its role in the loose dimer formation. These
dimers could be held together by base pairing between
TAR hairpins, while SL1 hairpins remain in close prox-
imity and conducive to maturation by interaction with
Gag/NC. It is likely that at the initiation stage of the di-
merization process, several regions are recognized by the
NC domain of Gag, with SL1 and TAR being the most
likely candidates. The fact that the main binding sites for
NCp8 map to the upper stem, but not to the apical loop of
SL1, suggests that recognition of this motif by NC is
possible regardless of the presence of a SL1/SL1 kissing-
loop interaction in the loose dimer. It had been demon-
strated that NC shows duplex destabilizing activity upon
interaction with distorted RNA structures (46,47,52,54).
Indeed, destabilization caused by the binding of oligo-
nucleotides and/or NCp8 to the upper part of the SL1
could be translated downstream to stem B leading to
PAL release. The PAL/PAL interaction can now enhance
the stability of the maturating HIV-2 RNA dimer. Our
data most probably reveal only the most stable inter-
faces within the immature dimer and we believe that
many more RNA/RNA and RNA/protein interactions
are involved in the dimer maturation process as previously
suggested (6).
In conclusion, we propose a model in which the upper
part of SL1 serves as a binding site for the NC domain of
Gag thus stimulating the initiation of HIV-2 dimerization,
without necessarily being a part of the tight dimer struc-
ture (Figure 6). Moreover, the kissing-loop formation
between TAR hairpins III in addition to the interaction
between SL1 apical loop palindromic sequences plays a
role in stabilizing HIV-2 loose dimers. However, the
SL1, once destabilized by NCp8, frees PAL for participa-
tion in a new type of intermolecular interaction which
appears to be involved in the formation of tight dimers.
It remains to be seen whether the TAR kissing-loop inter-
action is maintained throughout dimerization or is further
transformed to a more stable dimer element.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
Figure 6. Model of the HIV-2 dimerization initiation in vitro showing rearrangement in the PAL/SL1 region. Palindromic sequences within the SL1
apical loop and PAL are indicated in blue and in red, respectively. The NCp8 interaction region is presented as ellipse in orange.
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